The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Valeant Pharmaceuticals Intl.

  • VRX
  • NYSE
  • Consumer Products
  • Latest 116.28
  • Currency US$
  • Change -1.15
  • Percent Change -0.979 %
  • Volume 2,054,508
  • Mon Sep 22, 2014 04:06 PM EDT NYSE data delayed 15 minutes.
  • Open 117.88
  • Previous Close 117.43
  • High 118.23
  • Low 115.36
  • Bidx14 101.43
  • Askx3 123.66
  • 52-week High02/27 153.10
  • 52-week Low09/26 102.296
  • Beta 0.99
  • Market Cap 38,811.61M
  • EPS -2.39
  • P/E
  • Forward P/E 25.11
  • PEG 3.45
  • Annual Dividend 0.38
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $7,593,153,000
  • Earnings $-746,279,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow $1,797,461,000
  • Cash $531,200,000
  • Current Ratio 2.07

12 months ended Jun 30, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $27,895,600,000
  • Liabilities $22,528,300,000
  • Liabilities-to-Equity Ratio 4.20

Price Ratios

  • Price to Sales 5.13
  • Price to Book 6.68
  • Price to Cash Flow 21.69

Event Calendar

Event Last   Next  
Earnings Jul 31 $1.91 Oct 30 $0.61
Surprises Jul 31 1.05% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Sep 23, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The company is focused on the development and commercialization of medicines that address unmet medical needs in specialty CNS markets.

Related Securities
Symbol Type Latest % Chg

Officers

  • J. Michael Pearson Chairman & C.E.O.
  • Howard B. Schiller E.V.P. & C.F.O.
  • Brian Stolz E.V.P. of Administration & CHC
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: 17,200
  • Incorporation: Canada,
    n/a
  • Top 1000 Ranking: Profit: 965
    Revenue: 72
    Assets: 43

Head Office

2150 St. Elzear Blvd. West
Laval, QC
H7L 4A8

Phone: (514)-744-6792
Fax: (514)-7446272

ir@valeant.com
www.valeant.com

Ideas & Discussion

Live Discussion of VRX on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.